USFDA approves Alembic Pharmaceuticals' generic Doxorubicin Hydrochloride Liposome injection for various cancers, equivalent ...

Alembic Pharmaceuticals receives USFDA approval for its generic Doxorubicin Hydrochloride Liposome Injection used to treat ...

Alongside her husband, Bob Duggan, Maky Zanganeh has guided cancer drug developer Summit Therapeutics to reach staggering new ...

Alembic Pharmaceuticals shares surged over 12 per cent after receiving USFDA approval for its generic Doxorubicin ...

The much hyped weightloss drug Wegovy, also marketed as Ozempic, is expected to be in high demand when it becomes available in New Zealand from tomorrow. But the drug is unfunded so users hoping to ...

The approved ANDA is for the 20mg/10 ml (2mg/ml) and 50 mg/25 ml (2mg/ml) strength single-dose vials. It is therapeutically ...

The USFDA approved the abbreviated new drug application for Doxorubicin Hydrochloride Liposome injection and single-dose ...

Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple myeloma.

Lenacapavir is regarded as a significant step in improving prevention options for people at risk of HIV infection ...

Shares of Alembic Pharmaceuticals climbed over 12% after the company secured USFDA approval for its generic Doxorubicin ...

Stockholm, Sweden Monday, June 30, 2025, 10:00 Hrs [IST] ...

The FDA delivered two notable approvals for RSV immunization, UroGen overcame a negative advisory committee vote to secure an ...